Phenomenex Introduces bioZen Series for Characterization of Biotherapeutics

Torrance, Calif. (April 16, 2018) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces bioZen – a new series of LC solutions for bioseparations in pharmaceutical, biopharmaceutical and academic research. The series encompasses both proven and entirely new media spanning two particle platforms – core-shell... Read more

Sartorius Stedim Biotech and Penn State University announce partnership

University Park, Pennsylvania, USA | Goettingen, Germany, April 16, 2018 – Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will support the education and preparation of the next generation of biotechnology leaders. Part of Sartorius’ investment will be to... Read more

University of Pittsburgh and Thermo Fisher Scientific Establish Pharmacogenomics Center of Excellence

University of Pittsburgh and Thermo Fisher Scientific Establish Pharmacogenomics Center of Excellence Collaboration will support translational research that demonstrates the value of PGx in precision medicine PITTSBURGH, April 5, 2018 /PRNewswire/ — Thermo Fisher Scientific and the University of Pittsburgh have established a new Pharmacogenomics (PGx) Center of Excellence that combines expertise and technology in genomics,... Read more

FDA approves Lucentis (ranibizumab injection) 0.3 mg prefilled syringe for diabetic macular edema and diabetic retinopathy

Basel, 22 March 2018 FDA approves Lucentis (ranibizumab injection) 0.3 mg prefilled syringe for diabetic macular edema and diabetic retinopathy First and only prefilled syringe treatment option FDA-approved to treat all forms of diabetic retinopathy in people with or without diabetic macular edema (DME) Diabetic retinopathy is the leading cause of blindness among adults aged... Read more

WITec Releases TrueMatch – Integrated Raman Spectral Database Software

March 2018 TrueMatch is a powerful and innovative software component for accessing and developing Raman spectral databases WITec, manufacturer of 3D Raman imaging systems, is now offering TrueMatch, a powerful software component for accessing and creating Raman spectral databases. It can search existing libraries of Raman spectra to identify sample components and also allows users... Read more

QIAGEN launches CE-IVD assay to detect Trichomonas vaginalis in both female and male patients on the QIAsymphony RGQ platform

Germantown, Maryland, and Hilden, Germany, March 5th, 2018 – QIAGEN today announced the European launch of the artus T. vaginalis QS-RGQ Kit, a CE-marked molecular diagnostic test for the qualitative detection of the protozoan parasite T. vaginalis in both female and male patients. The artus T. vaginalis QS-RGQ Kit is an in vitro real-time polymerase... Read more

Bruker Names Burkhard Prause, President of Bruker Energy & Supercon Technologies (BEST), an Executive Officer of Bruker Corporation

BILLERICA, Mass., March 1, 2018 /PRNewswire/ — Bruker today announced the appointment of Dr. Burkhard Prause, the President of the Bruker Energy & Supercon Technologies (BEST) segment, as an executive officer of Bruker Corporation.  Dr. Prause has a successful track record of leading BEST through a significant expansion of its business in the last decade,... Read more

Agilent and Imperial College London Announce Collaboration Agreement

Agilent and Imperial College London Announce Collaboration Agreement Agilent Measurement Suite to provide researchers with greater experimental freedom SANTA CLARA, Calif., February 28, 2018 Agilent Technologies Inc. (NYSE: A) and Imperial College London today signed a strategic scientific collaboration agreement that brings together Agilent’s leading analytical technologies with Imperial’s outstanding researchers. Under the agreement, Agilent... Read more

GE Healthcare to License Duke University’s CT Organ Dosimetry Technology

Milwaukee (July 31, 2017) – GE Healthcare announced today that it has licensed Computed Tomography (CT) organ dosimetry technology developed at Duke University. The technology enables automatic calculation of organ dose, helping the clinician to better estimate the radiation exposure to the patient https://www.genewsroom.com/press-releases/ge-healthcare-license-duke-universitys-ct-organ-dosimetry-technology Read more

GE Healthcare to License Duke University’s CT Organ Dosimetry Technology

“This technology assesses organ doses in patients undergoing CT in an examination-specific manner, where granular dose estimates are precisely informed by the patient anatomy and the exact irradiation condition,” said Ehsan Samei, a professor of radiology, physics and biomedical engineering at Duke, who led development of the tool. “The technology includes a realistic estimation of... Read more